Publication | Open Access
Everolimus Plus Endocrine Therapy for Postmenopausal Women With Estrogen Receptor–Positive, Human Epidermal Growth Factor Receptor 2–Negative Advanced Breast Cancer
65
Citations
15
References
2018
Year
clinicaltrials.gov Identifier: NCT01698918.
| Year | Citations | |
|---|---|---|
Page 1
Page 1